Related Experiment Video
Updated: Aug 13, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Level of left ventricular dysfunction in endomyocardial biopsy-proven myocarditis
D Zivkov-Saponja1, A Stojsić-Milosavljević, D Stojsić
1Klinika za kardiologiju, Institut za kardiovaskularne bolesti, Sremska Kamenica.
Insights
Myocarditis significantly impairs heart function, leading to heart failure. Hemodynamic parameters like ejection fraction (EF) and end-diastolic pressure reveal systolic and diastolic dysfunction in active myocarditis patients.
Area of Science:
- Cardiology
- Pathophysiology
- Medical Diagnostics
Background:
- Myocarditis is linked to heart failure, but the extent of myocardial functional impairment is debated.
- Previous studies suggest global chronic or acute heart failure development in myocarditis patients.
Purpose of the Study:
- To identify hemodynamic parameters that describe myocardial systolic and diastolic impairment levels in myocarditis.
- To correlate hemodynamic findings with myocarditis severity based on Dallas Criteria.
Main Methods:
- Investigated 95 myocarditis patients and 36 controls using right and left heart catheterization.
- Performed endomyocardial biopsy (EMB) on a subset of patients.
- Classified patients into active myocarditis with fibrosis, active myocarditis without fibrosis, and borderline myocarditis groups.
Main Results:
- Left ventricle ejection fraction (EF), indicating systolic function, differed significantly from controls.
- Cardiac index showed no significant difference between patient and control groups.
- Elevated left ventricle end-diastolic pressure, signifying diastolic dysfunction, was observed in active myocarditis but not borderline cases.
Conclusions:
- Hemodynamic assessment, particularly EF and end-diastolic pressure, can effectively describe systolic and diastolic myocardial impairment in myocarditis.
- Active myocarditis is associated with both systolic and diastolic dysfunction, while borderline cases may show preserved diastolic function.
Abstract:
The level of myocardial functional impairment in the course of myocarditis still remains associated with controversial data. However, many investigators agree that there is a significant heart failure during myocarditis and a large number of studies suggest development of global chronic or acute heart failure. The objective of this study was to establish haemodynamic parameters as descriptors of the level of myocardial systolic and diastolic impairment. From 131 investigated patients, 95 were assigned to the study group and 36 to the control group. All patients underwent right and left heart catheterization. A group of patients underwent EMB (endomyocardial biopsy) of the right ventricle. According to the Dallas Criteria, patients were divided into three groups: active myocarditis with fibrosis, active myocarditis without fibrosis and borderline myocarditis. The following haemodynamic parameters were evaluated: left ventricle EF (ejection fraction), cardiac index and end diastolic pressure of the left ventricle. EF, which reflects left ventricular systolic impairment, showed a difference related to the control group, while there was no difference in cardiac index between the groups. Diastolic dysfunction (end diastolic pressure of the left ventricle) was noted in the group with active myocarditis, but not in the group with borderline myocarditis.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy